Peptides Codex
Home
Nonribosomal depsipeptide antibiotic

Teixobactin

Teixobactin is an 11-residue nonribosomal depsipeptide antibiotic from the soil bacterium Eleftheria terrae, discovered in 2015 using the iChip to grow previously unculturable microbes. It binds the conserved cell-wall precursors lipid II and lipid III, blocking both peptidoglycan and teichoic-acid synthesis, and no resistant mutants emerged in early laboratory studies. This page is educational and not medical advice.

By The Peptides Codex Editorial TeamReviewed July 10, 2026
Length
11 aa
Class
Nonribosomal depsipeptide antibiotic
Function
Binds lipid II and lipid III to block cell-wall and teichoic-acid synthesis
Context
Research antibiotic studied against Gram-positive pathogens

Discovered by culturing 'unculturable' soil bacteria, it killed pathogens with no detectable resistance in early studies.

Part of the Foundational & therapeutic peptides cluster

Overview

Teixobactin is an 11-residue nonribosomal depsipeptide antibiotic from the soil bacterium Eleftheria terrae, discovered in 2015 using the iChip to grow previously unculturable microbes. It binds the conserved cell-wall precursors lipid II and lipid III, blocking both peptidoglycan and teichoic-acid synthesis, and no resistant mutants emerged in early laboratory studies. This page is educational and not medical advice.

Source & context

Biological / chemical source: Soil bacterium Eleftheria terrae (isolated using the iChip)

Primary research or clinical context: Research antibiotic studied against Gram-positive pathogens

Discovery via the iChip

Teixobactin came from screening bacteria grown in situ in soil using the isolation chip (iChip), which coaxes microbes that will not grow on standard plates. Its 2015 report in Nature highlighted how untapped environmental bacteria remain a source of new antibiotic chemistry.

Mechanism and prospects

The peptide contains unusual residues, including enduracididine, and binds the pyrophosphate-sugar portion of lipid II and lipid III. Because these targets are non-protein and highly conserved, resistance was slow to appear in preclinical work against Staphylococcus aureus and Mycobacterium tuberculosis. It is inactive against Gram-negative bacteria and remains investigational.

FAQ about Teixobactin

What is Teixobactin?+

Teixobactin is an 11-residue nonribosomal depsipeptide antibiotic from the soil bacterium Eleftheria terrae, discovered in 2015 using the iChip to grow previously unculturable microbes. It binds the conserved cell-wall precursors lipid II and lipid III, blocking both peptidoglycan and teichoic-acid synthesis, and no resistant mutants emerged in early laboratory studies. This page is educational and not medical advice.

Is Teixobactin an approved medicine?+

Teixobactin is discussed here as a research / educational topic. Research antibiotic studied against Gram-positive pathogens. This is not medical advice.

What is the typical length of Teixobactin?+

Teixobactin is commonly described as approximately 11 amino acids (Nonribosomal depsipeptide antibiotic).

Related peptides

References & further reading

  1. 1.Wikipedia — Teixobactin
  2. 2.PubMed — A new antibiotic kills pathogens without detectable resistance (Nature 2015)
Disclaimer: Educational content only. Not medical advice. Not instructions for human use. Research peptides and unapproved products may be restricted or illegal to market for human consumption in your jurisdiction. Consult qualified professionals and applicable law.
You might also like: All peptides · Atlas · Research · Tools
Cite this: Peptides Codex — Teixobactin educational profile.
Tip: Use browser print (Ctrl/Cmd + P) for a clean PDF of this page.